#USA #New York #Class Action #Levi Korsinsky #Baxter International

Class Action Lawsuit Notification for Baxter International, Inc.

Levi & Korsinsky, LLP has officially notified shareholders of Baxter International, Inc. (NYSE: BAX) regarding a class action lawsuit that could have significant implications for investors. The lawsuit primarily focuses on allegations of securities fraud that occurred between February 23, 2022, and July 30, 2025.

Understanding the Class Action

The core of the lawsuit seeks to recover losses for shareholders who believe they were adversely affected by alleged fraudulent activities associated with Baxter's product, the Novum LVP. This particular product is critical in the healthcare sector, and claims have emerged that it experienced serious systemic defects leading to malfunctions.

Allegations Against Baxter International

The complaint surfaces alarming assertions including:

• - Systemic Defects: The Novum LVP reportedly malfunctioned, resulting in underinfusion, overinfusion, and non-delivery of fluids, thereby potentially endangering patients' lives.
• - Concealed Information: Baxter allegedly concealed important information related to these defects from investors.
• - Inadequate Remedies: Although Baxter reportedly attempted to alert customers about device malfunctions, many believe these efforts were insufficient given the ongoing dangers posed to patients.
• - Business Impact: As a result of these claims, there are rising concerns that existing Novum LVP devices could be withdrawn from service, possibly leading to a halt in new sales of these pumps.

What's Next for Affected Investors?

For those who may have incurred a loss during the specified timeframe, there’s a pivotal deadline arising quickly. Shareholders are encouraged to file their request to be appointed as the lead plaintiff by December 15, 2025. Even if one doesn’t serve in this capacity, participation in any recovery does not hinge on this role.

No Cost to Participate

One of the key benefits for class members is that they might be entitled to compensation with no out-of-pocket costs or fees. This means that for shareholders who have been affected, the process requires no financial burden to engage.

The Levi & Korsinsky Advantage

Levi & Korsinsky has built a robust reputation over the past two decades, having secured substantial compensation for shareholders. They emphasize their track record with complex securities litigation and boast a team of over 70 professionals dedicated to serving investors. Notably, they’ve consistently been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, validating their expertise in the domain of shareholder protection.

How to Get Involved

Shareholders looking to gain more insight into the class action or wishing to take action can directly contact:

• - Joseph E. Levi, Esq. at (212) 363-7500 or via email at [email protected].
• - An additional resource is the official class action submission form, accessible at https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=178346&wire=4.

This class action serves as a critical reminder for shareholders to remain vigilant about the companies they invest in, ensuring transparency and accountability from corporate entities. As this case unfolds, further updates will be vital for investors in navigating their rights and potential recoveries.